On today's podcast we run through the top COVID-19 stories including a steep rise in poison control calls; the authorization of an at-home testing kit; The hydroxychloroquine trial that's beginning soon; The trial evaluating ruxolitinib for COVID-19 associated cytokine storms; and the lab failures which have led to ineffective COVID-19 tests being sent from the CDC to nearly all of the 100 state and local public health labs.

We run through the latest COVID-19 news including results from a remdesivir trial; The blood purification system OK'd for patients in the ICU; A chloroquine trial halted early due to deaths; The saliva test that detects COVID19; And a bleaching agent product that is claiming to prevent COVID-19.

This week we run through the latest COVID-19 news including the shortage of critical meds, The CDC U-turn on face mask recommendations, Remdesivir trial enrollment, testing for COVID-19 antibodies, and new guidance from the FDA on blood donations aimed at helping maintain the supply.

This episodes covers the latest COVID-19 news including drug shortages, a new point-of-care diagnostic tool, the role of vitamin C, misuse of non-pharmacological chloroquine, and also some big news about a popular heartburn drug.

This week we talk about the latest on COVID-19, including the virus in relation to NSAID use; the pandemics knock on effect on drug shortages; a safety alert for fecal microbiota transplants; and potential flaws in EpiPen devices.